1. HDAC2- and EZH2-Mediated Histone Modifications Induce PDK1 Expression through miR-148a Downregulation in Breast Cancer Progression and Adriamycin Resistance
   Yunxia Xie et al, 2022, Cancers CrossRef
2. A novel AMPK activator shows therapeutic potential in hepatocellular carcinoma by suppressing HIF1α‐mediated aerobic glycolysis
   Hsing‐I Tseng et al, 2022, Molecular Oncology CrossRef
3. Natural Product-Based Glycolysis Inhibitors as a Therapeutic Strategy for Epidermal Growth Factor Receptor–Tyrosine Kinase Inhibitor-Resistant Non-Small Cell Lung Cancer
   Wonyoung Park et al, 2024, International Journal of Molecular Sciences CrossRef
4. Glucometabolic reprogramming: From trigger to therapeutic target in hepatocellular carcinoma
   Haoming Xia et al, 2022, Frontiers in Oncology CrossRef
5. Unraveling the Sweet Secrets of HCC: Glucometabolic Rewiring in Hepatocellular Carcinoma
   Sheraz Ahmad Bhat et al, 2023, Technology in Cancer Research & Treatment CrossRef
6. LncRNA SNHG6 promotes glycolysis reprogramming in hepatocellular carcinoma by stabilizing the BOP1 protein
   Kai Chen et al, 2022, Animal Cells and Systems CrossRef